020 3313 3274

Sharlene Reid


Miss Stacey Bryan (BSc MBBS MRCOG MD) is a consultant gynaecologist and gynaecological cancer surgeon at Imperial College Healthcare NHS Trust, where she completed her subspecialty training in gynaecological cancers. She obtained her undergraduate degrees in Biomedical Science and Medicine, at St George’s University of London in 2008, and membership to the Royal College of Obstetricians and Gynaecologists in 2015. She has undertaken research into HPV and early detection of cervical cancers and was awarded a Doctor of Medicine degree from the Institute of Women’s Health at University College London (UCL) in 2022. Her work has led to publications and presentations at both national and international conferences.

Miss Bryan’s practice focuses on the diagnosis and management of gynaecological issues including cancer and non-cancer. She specialises in complex benign and cancer surgery, as well as colposcopy and acute diagnostic services. As such she is able to offer a one stop service including gynaecological ultrasound scanning. She is the lead for Vulval Cancers at Imperial College London and has recently been appointed as Unit Training Lead as she is also passionate about education and training.


Vulval/vaginal cancer, cervical cancer, ovarian cancer, endometrial cancer, rapid diagnostics, pre-invasive cervical and vulval disease

Research & publications

Stacey J. Bryan, Jen Lee, Richard Gunu, Allison Jones, Adeola Olaitan, Adam N. Rosenthal, Ros J. Cutts, Isaac Garcia-Murillas, Nick Turner, Susan Lalondrelle, and Shreerang A. Bhide. Circulating HPV DNA as a Biomarker for Pre-Invasive and Early Invasive Cervical Cancer: A Feasibility Study. Cancers 2023, 15(9), 2590;

Heath, O. M., Bryan, S. J., Sohaib, A., & Barton, D. P. J. (2021). Laparoscopic assessment improves case selection for exenterative surgery in recurrent cervical and endometrial cancer. Journal of Obstetrics and Gynaecology, 41(8), 1252–1256.

Tsahalina E, Sohaib A, Mcaddy N, et al. EP1002 Secondary cytoreduction surgery for recurrent ovarian cancer – twelve radiological criteria for case selection: preliminary data. International Journal of Gynecologic Cancer 2019;29:A529.

Bryan S, Mahmoodi I, Kolomainen D, et al. EP700 Pelvic exenteration for recurrent gynaecological cancer- outcome of patients referred but not operated on. International Journal of Gynecologic Cancer 2019;29:A398.

Fernandes A, Bryan S, Kolomainen D, et al. What is life like after pelvic exenteration? The longitudinal assessment of quality of life after pelvic exenteration for recurrent/persistent gynaecological cancer. International Journal of Gynecologic Cancer 2019;29:A34.

Bryan, S., Barbara, C., Thomas, J. et al. HPV vaccine in the treatment of usual type vulval and vaginal intraepithelial neoplasia: a systematic review. BMC Women's Health 19, 3 (2019).

Private practice

Visit the Imperial College Healthcare Private care website